Home > Insider Trading > Filing (0001209191-17-046029)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1406338	Amit Sachdev	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Cro	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-07-19	20,000	$77.31	119,335	No	4	M	Direct
Common Stock	Disposition	2017-07-19	20,000	$161.00	99,335	No	4	S	Direct
Common Stock	Disposition	2017-07-21	800	$158.05	98,535	No	4	S	Direct
Common Stock	Disposition	2017-07-21	1,300	$158.90	97,235	No	4	S	Direct
Common Stock	Disposition	2017-07-21	500	$160.04	96,735	No	4	S	Direct
Common Stock	Disposition	2017-07-21	4,461	$161.44	92,274	No	4	S	Direct
Common Stock	Disposition	2017-07-21	1,564	$162.07	90,710	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Acquisiton	2017-07-19	20,000	$0.00	20,000	$77.31

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
21,250		2024-02-04	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	882	Indirect	401(k)

Footnotes

Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $158.05 (range $157.48 to $158.37).
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $158.90 (range $158.61 to $159.53).
Open market sales reported on this line occurred at a weighted average price of $160.04 (range $159.64 to $160.25).
Open market sales reported on this line occurred at a weighted average price of $161.44 (range $160.90 to $161.89)
Open market sales reported on this line occurred at a weighted average price of $162.07 (range $161.90 to $162.43).
The option vests in 16 quarterly installments from 02/05/2014.